US Stock MarketDetailed Quotes

IPHA Innate Pharma

Watchlist

1.891
+0.061+3.33%

Close Oct 31 16:00 ET

153.08MMarket Cap-4146P/E (TTM)

Innate Pharma Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(FY)Dec 31, 2023

(FY)Dec 31, 2022

(FY)Dec 31, 2021

(FY)Dec 31, 2020

(FY)Dec 31, 2019

(FY)Dec 31, 2018

(FY)Dec 31, 2017

(FY)Dec 31, 2016

(FY)Dec 31, 2015

(FY)Dec 31, 2014

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

-69.97%-32.56M

67.23%-19.16M

-12.92%-58.46M

-248.23%-51.77M

207.36%34.93M

32.32%-32.53M

-30.43%-48.06M

-118.28%-36.85M

1,211.66%201.59M

-65.35%-18.13M

Net income from continuing operations

86.97%-7.57M

-10.02%-58.1M

17.47%-52.81M

-208.22%-63.98M

-780.85%-20.76M

106.30%3.05M

-482.79%-48.39M

288.49%12.64M

65.87%-6.71M

-579.36%-19.65M

Operating gains losses

156.31%308K

48.69%-547K

-309.02%-1.07M

157.63%510K

61.67%-885K

-161.38%-2.31M

295.53%3.76M

-228.33%-1.92M

-131.62%-586K

-187.50%-253K

Depreciation and amortization

-88.79%5.09M

887.92%45.41M

-91.91%4.6M

243.62%56.8M

123.33%16.53M

68.47%7.4M

34.63%4.39M

22.90%3.26M

13.27%2.66M

166.36%2.34M

Other non cash items

-95.49%6K

114.35%133K

-301.52%-927K

-10.85%460K

102.35%516K

116.67%255K

-299.48%-1.53M

-897.92%-383K

-74.87%48K

32.64%191K

Change In working capital

-156.67%-32.09M

-26.48%-12.5M

79.91%-9.89M

-222.26%-49.21M

185.46%40.25M

-177.36%-47.1M

66.57%-16.98M

-124.75%-50.79M

15,882.00%205.17M

86.19%-1.3M

-Change in receivables

----

-163.38%-16.17M

---6.14M

----

-Change in payables and accrued expense

----

--2.87M

----

-Change in other current liabilities

----

--7.89M

----

-Change in other working capital

----

-120.39%-42.5M

--208.44M

----

Cash from discontinued investing activities

Operating cash flow

-69.97%-32.56M

67.23%-19.16M

-12.92%-58.46M

-248.23%-51.77M

207.36%34.92M

32.32%-32.53M

-30.42%-48.06M

-118.28%-36.85M

1,211.66%201.59M

-65.35%-18.13M

Investing cash flow

Cash flow from continuing investing activities

999.09%20.63M

304.69%1.88M

93.14%-917K

78.48%-13.37M

-355.85%-62.12M

180.23%24.28M

-150.01%-30.26M

152.18%60.51M

-2,931.95%-115.97M

-299.69%-3.83M

Capital expenditure reported

----

---2.34M

Net PPE purchase and sale

62.43%-201K

41.97%-535K

-2.67%-922K

29.35%-898K

-45.59%-1.27M

70.04%-873K

-115.85%-2.91M

-25.93%-1.35M

---1.07M

----

Net intangibles purchase and sale

-240.72%-2M

-46.38%-587K

96.13%-401K

83.82%-10.38M

-11,434.17%-64.13M

81.84%-556K

61.93%-3.06M

---8.04M

--0

----

Net business purchase and sale

----

50.00%-60K

Net investment purchase and sale

658.93%22.77M

--3M

--0

-250.00%-3M

-91.74%2M

194.12%24.22M

-136.81%-25.73M

160.84%69.9M

-7,980.17%-114.9M

-173.46%-1.42M

Net other investing changes

6,500.00%64K

-102.56%-1K

166.10%39K

-490.00%-59K

-121.74%-10K

-94.28%46K

--804K

----

-98.26%2K

Cash from discontinued investing activities

Investing cash flow

999.15%20.63M

304.69%1.88M

93.14%-917K

78.48%-13.37M

-355.86%-62.12M

182.41%24.28M

-148.69%-29.46M

152.18%60.51M

-2,933.53%-115.97M

-299.06%-3.82M

Financing cash flow

Cash flow from continuing financing activities

-7.55%-1.97M

-106.82%-1.83M

2,376.57%26.82M

-101.51%-1.18M

27.02%77.76M

6,591.04%61.22M

251.99%915K

-119.86%-602K

-93.68%3.03M

143.68%47.95M

Net issuance payments of debt

-16.54%-2.36M

-107.61%-2.03M

3,109.15%26.63M

-107.43%-885K

987.42%11.92M

-350.09%-1.34M

178.39%537K

-51.55%-685K

26.26%-452K

-295.22%-613K

Net common stock issuance

----

5.51%66.01M

--62.56M

----

-88.80%14K

-99.74%125K

150.01%47.72M

Cash dividends paid

--0

Proceeds from stock option exercised by employees

99.49%395K

-60.32%198K

939.58%499K

9.09%48K

-60.36%44K

-77.39%111K

154.40%491K

-94.48%193K

244.53%3.5M

139.95%1.02M

Net other financing activities

----

0.00%1K

200.00%1K

---1K

----

150.00%1K

-100.00%-2K

Cash from discontinued financing activities

Financing cash flow

-7.55%-1.97M

-106.82%-1.83M

2,378.59%26.82M

-101.51%-1.18M

27.02%77.77M

6,590.93%61.22M

251.99%915K

-119.85%-602K

-93.68%3.03M

143.69%47.95M

Net cash flow

Beginning cash position

-18.82%84.23M

-24.15%103.76M

-32.58%136.79M

33.20%202.89M

53.28%152.31M

-43.51%99.37M

15.07%175.91M

137.80%152.87M

67.59%64.29M

25.43%38.36M

Current changes in cash

27.27%-13.89M

41.32%-19.1M

50.91%-32.55M

-231.14%-66.31M

-4.54%50.57M

169.15%52.97M

-432.21%-76.61M

-73.99%23.06M

241.03%88.65M

235.28%25.99M

Effect of exchange rate changes

164.02%274K

11.39%-428K

-320.55%-483K

4,280.00%219K

119.23%5K

-139.39%-26K

386.96%66K

63.49%-23K

7.35%-63K

-395.65%-68K

End cash Position

-16.17%70.61M

-18.82%84.23M

-24.15%103.76M

-32.58%136.79M

33.20%202.89M

53.28%152.31M

-43.51%99.37M

15.07%175.91M

137.80%152.87M

67.59%64.29M

Free cash flow

-72.16%-34.91M

66.08%-20.28M

5.17%-59.79M

-106.87%-63.05M

10.25%-30.48M

37.21%-33.96M

-16.96%-54.09M

-123.06%-46.24M

1,079.23%200.52M

-79.62%-20.48M

Currency Unit

EUR

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

	(FY)Dec 31, 2023	(FY)Dec 31, 2022	(FY)Dec 31, 2021	(FY)Dec 31, 2020	(FY)Dec 31, 2019	(FY)Dec 31, 2018	(FY)Dec 31, 2017	(FY)Dec 31, 2016	(FY)Dec 31, 2015	(FY)Dec 31, 2014
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	-69.97%-32.56M	67.23%-19.16M	-12.92%-58.46M	-248.23%-51.77M	207.36%34.93M	32.32%-32.53M	-30.43%-48.06M	-118.28%-36.85M	1,211.66%201.59M	-65.35%-18.13M
Net income from continuing operations	86.97%-7.57M	-10.02%-58.1M	17.47%-52.81M	-208.22%-63.98M	-780.85%-20.76M	106.30%3.05M	-482.79%-48.39M	288.49%12.64M	65.87%-6.71M	-579.36%-19.65M
Operating gains losses	156.31%308K	48.69%-547K	-309.02%-1.07M	157.63%510K	61.67%-885K	-161.38%-2.31M	295.53%3.76M	-228.33%-1.92M	-131.62%-586K	-187.50%-253K
Depreciation and amortization	-88.79%5.09M	887.92%45.41M	-91.91%4.6M	243.62%56.8M	123.33%16.53M	68.47%7.4M	34.63%4.39M	22.90%3.26M	13.27%2.66M	166.36%2.34M
Other non cash items	-95.49%6K	114.35%133K	-301.52%-927K	-10.85%460K	102.35%516K	116.67%255K	-299.48%-1.53M	-897.92%-383K	-74.87%48K	32.64%191K
Change In working capital	-156.67%-32.09M	-26.48%-12.5M	79.91%-9.89M	-222.26%-49.21M	185.46%40.25M	-177.36%-47.1M	66.57%-16.98M	-124.75%-50.79M	15,882.00%205.17M	86.19%-1.3M
-Change in receivables	----	----	----	----	----	----	----	-163.38%-16.17M	---6.14M	----
-Change in payables and accrued expense	----	----	----	----	----	----	----	----	--2.87M	----
-Change in other current liabilities	----	----	----	----	----	----	----	--7.89M	----	----
-Change in other working capital	----	----	----	----	----	----	----	-120.39%-42.5M	--208.44M	----
Cash from discontinued investing activities
Operating cash flow	-69.97%-32.56M	67.23%-19.16M	-12.92%-58.46M	-248.23%-51.77M	207.36%34.92M	32.32%-32.53M	-30.42%-48.06M	-118.28%-36.85M	1,211.66%201.59M	-65.35%-18.13M
Investing cash flow
Cash flow from continuing investing activities	999.09%20.63M	304.69%1.88M	93.14%-917K	78.48%-13.37M	-355.85%-62.12M	180.23%24.28M	-150.01%-30.26M	152.18%60.51M	-2,931.95%-115.97M	-299.69%-3.83M
Capital expenditure reported	----	----	----	----	----	----	----	----	----	---2.34M
Net PPE purchase and sale	62.43%-201K	41.97%-535K	-2.67%-922K	29.35%-898K	-45.59%-1.27M	70.04%-873K	-115.85%-2.91M	-25.93%-1.35M	---1.07M	----
Net intangibles purchase and sale	-240.72%-2M	-46.38%-587K	96.13%-401K	83.82%-10.38M	-11,434.17%-64.13M	81.84%-556K	61.93%-3.06M	---8.04M	--0	----
Net business purchase and sale	----	----	----	----	----	----	----	----	----	50.00%-60K
Net investment purchase and sale	658.93%22.77M	--3M	--0	-250.00%-3M	-91.74%2M	194.12%24.22M	-136.81%-25.73M	160.84%69.9M	-7,980.17%-114.9M	-173.46%-1.42M
Net other investing changes	6,500.00%64K	-102.56%-1K	166.10%39K	-490.00%-59K	-121.74%-10K	-94.28%46K	--804K	----	----	-98.26%2K
Cash from discontinued investing activities
Investing cash flow	999.15%20.63M	304.69%1.88M	93.14%-917K	78.48%-13.37M	-355.86%-62.12M	182.41%24.28M	-148.69%-29.46M	152.18%60.51M	-2,933.53%-115.97M	-299.06%-3.82M
Financing cash flow
Cash flow from continuing financing activities	-7.55%-1.97M	-106.82%-1.83M	2,376.57%26.82M	-101.51%-1.18M	27.02%77.76M	6,591.04%61.22M	251.99%915K	-119.86%-602K	-93.68%3.03M	143.68%47.95M
Net issuance payments of debt	-16.54%-2.36M	-107.61%-2.03M	3,109.15%26.63M	-107.43%-885K	987.42%11.92M	-350.09%-1.34M	178.39%537K	-51.55%-685K	26.26%-452K	-295.22%-613K
Net common stock issuance	----	----	----	----	5.51%66.01M	--62.56M	----	-88.80%14K	-99.74%125K	150.01%47.72M
Cash dividends paid	--0	--0	--0	--0	--0	--0	--0	--0	--0	--0
Proceeds from stock option exercised by employees	99.49%395K	-60.32%198K	939.58%499K	9.09%48K	-60.36%44K	-77.39%111K	154.40%491K	-94.48%193K	244.53%3.5M	139.95%1.02M
Net other financing activities	----	----	0.00%1K	0.00%1K	200.00%1K	---1K	----	----	150.00%1K	-100.00%-2K
Cash from discontinued financing activities
Financing cash flow	-7.55%-1.97M	-106.82%-1.83M	2,378.59%26.82M	-101.51%-1.18M	27.02%77.77M	6,590.93%61.22M	251.99%915K	-119.85%-602K	-93.68%3.03M	143.69%47.95M
Net cash flow
Beginning cash position	-18.82%84.23M	-24.15%103.76M	-32.58%136.79M	33.20%202.89M	53.28%152.31M	-43.51%99.37M	15.07%175.91M	137.80%152.87M	67.59%64.29M	25.43%38.36M
Current changes in cash	27.27%-13.89M	41.32%-19.1M	50.91%-32.55M	-231.14%-66.31M	-4.54%50.57M	169.15%52.97M	-432.21%-76.61M	-73.99%23.06M	241.03%88.65M	235.28%25.99M
Effect of exchange rate changes	164.02%274K	11.39%-428K	-320.55%-483K	4,280.00%219K	119.23%5K	-139.39%-26K	386.96%66K	63.49%-23K	7.35%-63K	-395.65%-68K
End cash Position	-16.17%70.61M	-18.82%84.23M	-24.15%103.76M	-32.58%136.79M	33.20%202.89M	53.28%152.31M	-43.51%99.37M	15.07%175.91M	137.80%152.87M	67.59%64.29M
Free cash flow	-72.16%-34.91M	66.08%-20.28M	5.17%-59.79M	-106.87%-63.05M	10.25%-30.48M	37.21%-33.96M	-16.96%-54.09M	-123.06%-46.24M	1,079.23%200.52M	-79.62%-20.48M
Currency Unit	EUR	EUR	EUR	EUR	EUR	EUR	EUR	EUR	EUR	EUR
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	Unqualified Opinion	Unqualified Opinion	Unqualified Opinion	--	--	--	--	--	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

No Data